Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Premedication Timing on Endoscopy Visibility
NCT06581783Completed
- Sponsor
- Asian Institute of Gastroenterology
- Start
- Dec 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of simethicone and acetylcysteine (4 arms), sponsored by Asian Institute of Gastroenterology. Primary endpoint: Comparison of Mucosal Visibility. Started Dec 2024; status: completed.
02
Drugs
simethiconeacetylcysteine
Beyond the preview
Go deeper on NCT06581783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06581783.